国家自然科学基金面上项目（2024.01-2027.12），MuERV-L临接的lncRNA在小鼠合子基因组激活中的功能和作用机制。

科技部重点研发项目子课题（2022.12-2027.11），胚层类器官模型标准化制备与药物筛选。

国家自然科学基金面上项目（2022.01-2025.12），重复序列RNA在多能性细胞命运决定中的功能和作用机制。

科技部重点研发项目子课题（2019.07-2024.06），心脏前体细胞的精确定位及表观遗传分析。

科技部重点研发项目子课题（2018.12-2021.12），早期胚胎去分化和全能性维持的分子调控机制。

国家自然科学基金面上项目（2019.01-2022.12），NEDD8激活酶UBA3在干细胞多能性获得与维持中的作用机制。

1. Chen K*, Liu W*, Zhu J*, Kou X, Zhao Y, Wang H,Jiang C#, Gao S#, Kang L# (2024)

Pivotalrole for long noncoding RNAs in zygotic genome activation in mice.

Science China LifeSciences 2024 Jan 26.

2. Zhu J*, Chen K*, Sun Y*, Ye W, Liu J, Zhang D, SuN, Kou X, Zhao Y, Wang H, Gao S#,Kang L#(2023)

LSM1-mediated Major Satellite RNA decay is required for nonequilibrium histone H3.3 incorporation into parental pronuclei.

Nature Communications 2023 Feb 21;14(1):957. 

3. Wu L*, He S*, Ye W, Shen J, Zhao K, Zhang Y, Zhang R, Wei J,Cao S, Chen K, Le R, Xi C, Kou X, Zhao Y, Wang H, Kang L#, Gao S# (2021)

Surf4 facilitates reprogramming by activating the cellular response to endoplasmic reticulum stress. 

Cell Proliferation 2021 Nov;54(11):e13133. 

4. He J*, Ye W*, Kou N*, Chen K, Cui B, Zhang X, HuS, Liu T#,Kang L#, Li X#(2020)

MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion viaIL32/AKT signalling pathway. 

Journal of Cellular and Molecular Medicine 2020 Jan;24(1):841-849. 

5. Kang L*, Chen JY*, Gao SR# (2018)

Historical review of reprogramming and pluripotent stem cell research in China. 

Yi Chuan 2018 Oct 20;40(10):825-840.

6. Wu L*, Wu Y, Peng B, Hou Z, Dong Y, Chen K, Guo M, Li H, Chen X, Kou X, Zhao Y, BiY, Wang Y, Wang H, Le R#, Kang L#, Gao S#(2017)

Oocyte-Specific Homeobox 1, Obox1, Facilitates Reprogramming by Promoting Mesenchymal-to-Epithelial Transition and Mitigating Cell Hyperproliferation. Stem Cell Reports 9(5):1692-1705.

7. Li X*, Ma C*, Zhang L*, Li N, Zhang X, He J, HeR, Shao M, Wang J, Kang L#, Han C# (2017)

LncRNA AC132217.4,a KLF8-regulated long non-coding RNA, facilitates oral squamous cell carcinoma metastasis by upregulating IGF2 expression.

Cancer Letters 407:45-56.

8. Feng X*, Xu X*, Xiao X*, Zou K*, Yu W, Wu J, Tang R, Gao Y, Hao J,Zhao X, Liao Y, Chen Y, Huang W, Guo W#, Kang L#, Deng W#(2017)

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.

Cell Death & Disease 8(5):e2783. 

9. Wang M*, Zhang Y*, Wang T*, Zhang J*, Zhou Z, Sun Y, Wang S, Shi Y, Luan X, Zhang Y, Wang Y, Wang Y, Zou Z#, Kang L#, Liu H# (2017)

The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status.

Cellular Physiology and Biochemistry 43(5):1755-1766.

10. Hao J*, Xu H*, Luo M*, Yu W*, Chen M, Liao Y, Zhang C, Zhao X, Jiang W, Hou S, Feng X, Zou K, Chen Y, Huang W, Guo W#, Kang L#, Deng W#(2017)

The tumor-promoting role of TRIP4 in melanoma progression and its involvement in responseto BRAF-targeted therapy.

Journal of Investigative Dermatology 138(1):159-170.

11. Kang L*, Gao S#.(2015)

Generation of Viable Mice from Induced Pluripotent Stem Cells (iPSCs) Through Tetraploid Complementation.

Methods in Molecular Biology. 2015;1330:125-32.

12. Kang L#*, Wu J*, Tao Y*, Li H, Liu X, Gao S#, Wang Q#(2015)

Cell Type-Specific Expression Profile and Signaling Requirements in Early Hematopoietic Reprogramming.

Stem Cells and Development 24(12):1483-92. 

13. Kang L*,Gao S# (2012)

Pluripotency of induced pluripotent stem cells.

Journal of Animal Science andBiotechnology 2012 Feb 28;3(1):5. 

14. Kang L*, Wu T, Tao Y, Yuan Y, He J, Zhang Y, Luo T, Kou Z, Gao S# (2011)

Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation.

Cell Research 21(3):546-9. 

15. Kang L*, Kou Z*, Zhang Y, Gao S# (2010)

Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.

Journal of Genetics and Genomics 7(7):415-21. 

16. Kou Z*, Kang L*, Yuan Y, Tao Y, Zhang Y, Wu T, HeJ, Wang J, Liu Z, Gao S# (2010)

Mice cloned from induced pluripotent stem cells(iPSCs).

Biology of Reproduction 83(2):238-43. 

17. Kang L*, Wang J, Zhang Y, Kou Z, Gao S# (2009)

iPS cells can support full term development of tetraploid blastocyst-complemented embryos.

Cell Stem Cell 5(2):135-138.